BCAB Next Earnings Date Notes

— BioAtla, Inc. (BCAB) is a clinical-stage biopharmaceutical company focused on developing novel, conditionally active biologic (CAB) antibody therapies for treating cancer. The company's core platform leverages its CAB technology to engineer antibodies & antibody-drug conjugates (ADCs) that remain inactive in healthy tissues but are activated in the tumor microenvironment, potentially improving both safety & efficacy. As an investor preparing for the next BCAB earnings call, key business metrics to monitor include clinical trial progress & data readouts, especially for lead assets like BA3011 & BA3021, which target solid tumors. Watch for updates on enrollment, response rates, duration of response, & advancement toward pivotal studies. Additionally, take note of the company's cash balance, runway projections, R&D spending, and any announced partnerships or licensing deals. Pipeline expansion and progress in earlier-stage programs also matter for long-term prospects. Ultimately, successful clinical validation, regulatory milestones, and potential collaboration or licensing agreements will be the most critical indicators of BCAB's path to creating shareholder value. The next projected earnings date for BCAB is 3/30/2026 after close (stay tuned for a confirmed earnings date once announced).

BCAB Next Earnings Date FAQ

On this page we presented the BCAB Next Earnings Date information for BioAtla along with recent past earnings dates. For Q3 of 2025, BCAB reported earnings of -0.270/share, with the earnings report taking place on 11/13/2025. For Q2 of 2025, BCAB reported earnings of -0.320/share, with the earnings report taking place on 8/7/2025. For Q1 of 2025, BCAB reported earnings of -0.260/share, with the earnings report taking place on 5/6/2025. For Q4 of 2024, BCAB reported earnings of -0.300/share, with the earnings report taking place on 3/27/2025. For Q3 of 2024, BCAB reported earnings of -0.220/share, with the earnings report taking place on 11/7/2024. Based on these past earnings dates, the projected next earnings date for BCAB is 3/30/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as BioAtla. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to BioAtla shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research BioAtla next earnings dates as well as any other stock out there in our coverage universe, to see when the next BCAB earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up BCAB's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the BCAB next earnings date.